Back
 ABC  Vol.7 No.1 , February 2017
A Thiazole Analogue Exhibits an Anti-Proliferative Effect in Different Human Carcinoma Cell Lines and Its Mechanism Based on Molecular Modeling
Abstract: Purpose: Aim of this study is to assess the anti-proliferative effect of the thiazole analogue (5-acetyl-4-methyl-2-(3-pyridyl) thiazole) with different human carcinoma cell lines and to postulate its possible mechanism of action using molecular modeling. Methods: Three different human carcinoma cell lines were used namely hepatocyte carcinoma (HEPG2), breast adenocarcinoma (MCF7) and colon cancer (HCT116). Molecular docking simulations for tested thiazole analogue and its virtual analogues against the cytochrome P-450 2A6 enzyme and mutated SOD were performed. Results: Cell lines cytotoxicity revealed that the tested thiazole analogue exerts a significant anti-proliferative activity in all the used human carcinoma cell lines with a pronounced anti-proliferative effect in liver carcinoma cell line HEPG2 (IC50 = 23.8 μg/ml) whereas the anti-proliferative effect in colon carcinoma and breast cancer cell lines was poor with IC50 = 50 μg/ml and IC50 > 50 μg/ml respectively. The postulated mechanism of action revealed the high affinity to inhibit SOD and CYP2A6 enzymes in the liver. Conclusion: The thiazole analogue (5-acetyl-4-methyl-2-(3-pyridyl)thiazole) is a potential liver specific anticancer agent capable of interfering with both apoptotic signaling pathway and the free radical processing in liver which leads to more studies on liver cancer from different perspective rather than the apoptotic signaling pathway.
Cite this paper: Amin, H. , El-Araby, A. , Eid, S. , Nasr, T. , Bondock, S. , Leheta, O. and Dawoud, M. (2017) A Thiazole Analogue Exhibits an Anti-Proliferative Effect in Different Human Carcinoma Cell Lines and Its Mechanism Based on Molecular Modeling. Advances in Biological Chemistry, 7, 76-87. doi: 10.4236/abc.2017.71005.
References

[1]   Gibbs, J.B. (2000) Mechanism-Based Target Identification and Drug Discovery in Cancer Research. Science, 287, 1969-1973.
https://doi.org/10.1126/science.287.5460.1969

[2]   Cragg, G.M., Grothaus, P.G. and Newman, D.J. (2009) Impact of Natural Products on Developing New Anti-Cancer Agents. Chemical Reviews, 109, 3012-3043.
https://doi.org/10.1021/cr900019j

[3]   McFadyen, M.C., Melvin, W.T. and Murray, G.I. (2004) Cytochrome P450 Enzymes: Novel Options for Cancer Therapeutics. Molecular Cancer Therapeutics, 3, 363-371.

[4]   Otyepka, M., Skopalik, J., Anzenbacherova, E. and Anzenbacher, P. (2007) What Common Structural Features and Variations of Mammalian P450s Are Known to Date? Biochimica et Biophysica Acta, 1770, 376-389.
https://doi.org/10.1016/j.bbagen.2006.09.013

[5]   Yano, J.K., Denton, T.T., Cerny, M.A., Zhang, X., Johnson, E.F. and Cashman, J.R. (2006) Synthetic Inhibitors of Cytochrome P-450 2A6: Inhibitory Activity, Difference Spectra, Mechanism of Inhibition, and Protein Cocrystallization. Journal of Medicinal Chemistry, 49, 6987-7001.
https://doi.org/10.1021/jm060519r

[6]   Yano, J.K., Hsu, M.H., Griffin, K.J., Stout, C.D. and Johnson, E.F. (2005) Structures of Human Microsomal Cytochrome P450 2A6 Complexed with Coumarin and Methoxsalen. Nature structural & Molecular Biology, 12, 822-823.
https://doi.org/10.1038/nsmb971

[7]   Hoffman, S.M., Nelson, D.R. and Keeney, D.S. (2001) Organization, Structure and Evolution of the CYP2 Gene Cluster on Human Chromosome 19. Pharmacogenetics, 11, 687-698.
https://doi.org/10.1097/00008571-200111000-00007

[8]   Ioannides, C. (2008) Cytochromes P450: Role in the Metabolism and Toxicity of Drugs and Other Xenobiotics. Royal Society of Chemistry, London.

[9]   Abu-Bakar, A., Arthur, D.M., Wikman, A.S., Rahnasto, M., Juvonen, R.O., Vepsalainen, J., Raunio, H., Ng, J.C. and Lang, M.A. (2012) Metabolism of Bilirubin by Human Cytochrome P450 2A6. Toxicology and Applied Pharmacology, 261, 50-58.
https://doi.org/10.1016/j.taap.2012.03.010

[10]   Raunio, H., Juvonen, R., Pasanen, M., Pelkonen, O., Paakko, P. and Soini, Y. (1998) Cytochrome P4502A6 (CYP2A6) Expression in Human Hepatocellular Carcinoma. Hepatology, 27, 427-432.
https://doi.org/10.1002/hep.510270217

[11]   Nakajima, M., Itoh, M., Sakai, H., Fukami, T., Katoh, M., Yamazaki, H., Kadlubar, F.F., Imaoka, S., Funae, Y. and Yokoi, T. (2006) CYP2A13 Expressed in Human Bladder Metabolically Activates 4-Aminobiphenyl. International Journal of Cancer, 119, 2520-2526.
https://doi.org/10.1002/ijc.22136

[12]   McCord, J.M. and Fridovich, I. (1969) Superoxide Dismutase. An Enzymic Function for Erythrocuprein (Hemocuprein). The Journal of Biological Chemistry, 244, 6049-6055.

[13]   Hough, M.A. and Hasnain, S.S. (1999) Crystallographic Structures of Bovine Copper-Zinc Superoxide Dismutase Reveal Asymmetry in Two Subunits: Functionally Important Three and Five Coordinate Copper Sites Captured in the Same Crystal. Journal of Molecular Biology, 287, 579-592.
https://doi.org/10.1006/jmbi.1999.2610

[14]   Strange, R.W., Hough, M.A., Antonyuk, S.V. and Hasnain, S.S. (2012) Structural Evidence for a Copper-Bound Carbonate Intermediate in the Peroxidase and Dismutase Activities of Superoxide Dismutase. PLoS ONE, 7, e44811.
https://doi.org/10.1371/journal.pone.0044811

[15]   Bordo, D., Pesce, A., Bolognesi, M., Elena Stroppolo, M., Falconi, M. and Desideri, A. (2001) Copper-Zinc Superoxide Dismutase in Prokaryotes and Eukaryotes. In: Messerschmidt, A., Huber, R., Wieghardt, K. and Poulos, T., Eds., Handbook of Metalloproteins, John Wiley & Sons, Hoboken, 6.

[16]   Banci, L., Bertini, I., Cramaro, F., Del Conte, R. and Viezzoli, M.S. (2002) The Solution Structure of Reduced Dimeric Copper Zinc Superoxide Dismutase. The Structural Effects of Dimerization. European Journal of Biochemistry/FEBS, 269, 1905-1915.
https://doi.org/10.1046/j.1432-1033.2002.02840.x

[17]   Sharma, R.N., Xavier, F.P., Vasu, K.K., Chaturvedi, S.C. and Pancholi, S.S. (2009) Synthesis of 4-Benzyl-1,3-Thiazole Derivatives as Potential Anti-Inflammatory Agents: An Analogue-Based Drug Design Approach. Journal of Enzyme Inhibition and Medicinal Chemistry, 24, 890-897.
https://doi.org/10.1080/14756360802519558

[18]   Medan, D., Wang, L., Toledo, D., Lu, B., Stehlik, C., Jiang, B.H., Shi, X. and Rojanasakul, Y. (2005) Regulation of Fas (CD95)-Induced Apoptotic and Necrotic Cell Death by Reactive Oxygen Species in Macrophages. Journal of Cellular Physiology, 203, 78-84.
https://doi.org/10.1002/jcp.20201

[19]   Krchnak, V. and Holladay, M.W. (2002) Solid Phase Heterocyclic Chemistry. Chemical Reviews, 102, 61-91.
https://doi.org/10.1021/cr010123h

[20]   Carter, J.S., Kramer, S., Talley, J.J., Penning, T., Collins, P., Graneto, M.J., Seibert, K., Koboldt, C.M., Masferrer, J. and Zweifel, B. (1999) Synthesis and Activity of Sulfonamide-Substituted 4,5-Diaryl Thiazoles as Selective Cyclooxygenase-2 Inhibitors. Bioorganic & Medicinal Chemistry Letters, 9, 1171-1174.
https://doi.org/10.1016/S0960-894X(99)00157-2

[21]   Bell, F.W., Cantrell, A.S., Hogberg, M., Jaskunas, S.R., Johansson, N.G., Jordan, C.L., Kinnick, M.D., Lind, P., Morin, J.M., Jr., Noreen, R., et al. (1995) Phenethylthiazolethiourea (PETT) Compounds, a New Class of HIV-1 Reverse Transcriptase Inhibitors. 1. Synthesis and Basic Structure-Activity Relationship Studies of PETT Analogs. Journal of Medicinal Chemistry, 38, 4929-4936.
https://doi.org/10.1021/jm00025a010

[22]   Desai, N.C., Rajpara, K.M., Joshi, V.V., Vaghani, H.V. and Satodiya, H.M. (2012) Synthesis and Characterization of Some New Thiazole Based Thiazolidinone Derivatives as Potent Antimicrobial and Antimycobacterial Agents. Anti-Infective Agents, 10, 75-86.
https://doi.org/10.2174/2211362611208020075

[23]   Jisha, M., Kamalabhai, A., Babu, G. and Biju, C. (2013) Synthesis, Characterization and in Vitro Anticancer Screening of Novel Thiazole-1, 3, 4-Oxadiazole Hybrid Analogues. Journal of Chemical and Pharmaceutical Research, 5, 64-70.

[24]   Rudolph, J., Theis, H., Hanke, R., Endermann, R., Johannsen, L. and Geschke, F. (2001) Seco-Cyclothialidines: New Concise Synthesis, Inhibitory Activity toward Bacterial and Human DNA Topoisomerases, and Antibacterial Properties. Journal of Medicinal Chemistry, 44, 619-626.
https://doi.org/10.1021/jm0010623

[25]   Radhakrishnan, S.K., Bhat, U.G., Hughes, D.E., Wang, I.C., Costa, R.H. and Gartel, A.L. (2006) Identification of a Chemical Inhibitor of the Oncogenic Transcription Factor Forkhead Box M1. Cancer Research, 66, 9731-9735.
https://doi.org/10.1158/0008-5472.CAN-06-1576

[26]   Bhat, U.G., Zipfel, P.A., Tyler, D.S. and Gartel, A.L. (2008) Novel Anticancer Compounds Induce Apoptosis in Melanoma Cells. Cell Cycle, 7, 1851-1855.
https://doi.org/10.4161/cc.7.12.6032

[27]   Chang, S., Zhang, Z., Zhuang, X., Luo, J., Cao, X., Li, H., Tu, Z., Lu, X., Ren, X. and Ding, K. (2012) New Thiazolecarboxamides as Potent Inhibitors of Akt Kinases. Bioorganic & Medicinal Chemistry Letters, 22, 1208-1212.
https://doi.org/10.1016/j.bmcl.2011.11.080

[28]   Bondock, S., Naser, T. and Ammar, Y.A. (2013) Synthesis of Some New 2-(3-pyridyl)-4,5-disubstituted Thiazoles as Potent Antimicrobial Agents. European Journal of Medicinal Chemistry, 62, 270-279.
https://doi.org/10.1016/j.ejmech.2012.12.050

[29]   Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, J.T., Bokesch, H., Kenney, S. and Boyd, M.R. (1990) New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening. Journal of the National Cancer Institute, 82, 1107-1112.
https://doi.org/10.1093/jnci/82.13.1107

[30]   Kershaw, N.M., Wright, G.S., Sharma, R., Antonyuk, S.V., Strange, R.W., Berry, N.G., O’Neill, P.M. and Hasnain, S.S. (2013) X-Ray Crystallography and Computational Docking for the Detection and Development of Protein-Ligand Interactions. Current Medicinal Chemistry, 20, 569-575.

[31]   Pelkonen, O., Rautio, A., Raunio, H. and Pasanen, M. (2000) CYP2A6: A Human Coumarin 7-Hydroxylase. Toxicology, 144, 139-147.
https://doi.org/10.1016/S0300-483X(99)00200-0

[32]   Fridovich, I. (1995) Superoxide Radical and Superoxide Dismutases. Annual Review of Biochemistry, 64, 97-112.
https://doi.org/10.1146/annurev.bi.64.070195.000525

[33]   Marklund, S.L., Westman, N.G., Lundgren, E. and Roos, G. (1982) Copper- and Zinc-Containing Superoxide Dismutase, Manganese-Containing Superoxide Dismutase, Catalase, and Glutathione Peroxidase in Normal and Neoplastic Human Cell Lines and Normal Human Tissues. Cancer Research, 42, 1955-1961.

[34]   Shulyakovskaya, T., Sumegi, L. and Gal, D. (1993) In Vivo Experimental Studies on the Role of Free Radicals in Photodynamic Therapy. I. Measurement of the Steady State Concentration of Free Radicals in Tumor Tissues of Mice. Biochemical and Biophysical Research Communications, 195, 581-587.
https://doi.org/10.1006/bbrc.1993.2085

[35]   Van Driel, B.E. and Van Noorden, C.J. (1999) Oxygen Insensitivity of the Histochemical Assay of Glucose-6-Phosphate Dehydrogenase Activity for the Discrimination between Nonmalignant and Malignant Cells. The Journal of Histochemistry and Cytochemistry, 47, 575-582.
https://doi.org/10.1177/002215549904700501

[36]   Marzo, I., Brenner, C., Zamzami, N., Jürgensmeier, J.M., Susin, S.A., Vieira, H.L., Prévost, M.-C., Xie, Z., Matsuyama, S. and Reed, J.C. (1998) Bax and Adenine Nucleotide Translocator Cooperate in the Mitochondrial Control of Apoptosis. Science, 281, 2027-2031.
https://doi.org/10.1126/science.281.5385.2027

[37]   Vander Heiden, M.G., Chandel, N.S., Williamson, E.K., Schumacker, P.T. and Thompson, C.B. (1997) Bcl-xL Regulates the Membrane Potential and Volume Homeostasis of Mitochondria. Cell, 91, 627-637.
https://doi.org/10.1016/S0092-8674(00)80450-X

[38]   Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S.M., Ahmad, M., Alnemri, E.S. and Wang, X. (1997) Cytochrome c and dATP-Dependent Formation of Apaf-1/Cas-pase-9 Complex Initiates an Apoptotic Protease Cascade. Cell, 91, 479-489.
https://doi.org/10.1016/S0092-8674(00)80434-1

[39]   D’Amato, R.J., Lin, C.M., Flynn, E., Folkman, J. and Hamel, E. (1994) 2-Methoxye-stradiol, an Endogenous Mammalian Metabolite, Inhibits Tubulin Polymerization by Interacting at the Colchicine Site. Proceedings of the National Academy of Sciences of the United States of America, 91, 3964-3968.
https://doi.org/10.1073/pnas.91.9.3964

[40]   Fotsis, T., Zhang, Y., Pepper, M.S., Adlercreutz, H., Montesano, R., Nawroth, P.P. and Schweigerer, L. (1994) The Endogenous Oestrogen Metabolite 2-Methoxyoes-tradiol Inhibits Angiogenesis and Suppresses Tumour Growth. Nature, 368, 237-239.
https://doi.org/10.1038/368237a0

[41]   Antonyuk, S., Strange, R.W. and Hasnain, S.S. (2010) Structural Discovery of Small Molecule Binding Sites in Cu-Zn Human Superoxide Dismutase Familial Amyotrophic Lateral Sclerosis Mutants Provides Insights for Lead Optimization. Journal of Medicinal Chemistry, 53, 1402-1406.
https://doi.org/10.1021/jm9017948

[42]   Kim, D., Wu, Z.L. and Guengerich, F.P. (2005) Analysis of Coumarin 7-Hydroxy-lation Activity of Cytochrome P450 2A6 Using Random Mutagenesis. The Journal of Biological Chemistry, 280, 40319-40327.
https://doi.org/10.1074/jbc.M508171200

[43]   Khojasteh-Bakht, S.C., Koenigs, L.L., Peter, R.M., Trager, W.F. and Nelson, S.D. (1998) (R)-(+)-Menthofuran Is a Potent, Mechanism-Based Inactivator of Human Liver Cytochrome P450 2A6. Drug Metabolism and Disposition: The Biological Fate of Chemicals, 26, 701-704.

 
 
Top